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ABSTRACT The E2F transcription factors are important regulators of the cell cycle whose function is
commonly misregulated in cancer. To identify novel regulators of E2F1 activity in vivo, we used Drosophila
to conduct genetic screens. For this, we generated transgenic lines that allow the tissue-speciﬁc depletion
of dE2F1 by RNAi. Expression of these transgenes using Gal4 drivers in the eyes and wings generated
reliable and modiﬁable phenotypes. We then conducted genetic screens testing the capacity of Exelixis
deﬁciencies to modify these E2F1-RNAi phenotypes. From these screens, we identiﬁed mutant alleles of
Suppressor of zeste 2 [Su(z)2] and multiple Polycomb group genes as strong suppressors of the E2F1-RNA
interference phenotypes. In validation of our genetic data, we ﬁnd that depleting Su(z)2 in cultured Dro-
sophila cells restores the cell-proliferation defects caused by reduction of dE2F1 by elevating the level of
dE2f1. Furthermore, analyses of methylation status of histone H3 lysine 27 (H3K27me) from the published
modENCODE data sets suggest that the genomic regions harboring dE2f1 gene and certain dE2f1 target
genes display H3K27me during development and in several Drosophila cell lines. These in vivo observa-
tions suggest that the Polycomb group may regulate cell proliferation by repressing the transcription of
dE2f1 and certain dE2F1 target genes. This mechanism may play an important role in coordinating cellular
differentiation and proliferation during Drosophila development.
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The E2F family of transcription factors provides temporal control of
genes that are necessary for the G1/S-phase transition and are critical
for controlling cell proliferation (Burkhart and Sage 2008; van den
Heuvel and Dyson 2008). In early G1 phase of the cell cycle, the RB
family proteins bind to and inhibit E2F transcriptional activities. In
late G1 to S phase, cyclin-dependent kinases (CDKs) phosphorylate
the RB family proteins, which then dissociate, resulting in E2F liber-
ation and activation of E2F-dependent transcription (Burkhart and
Sage 2008; van den Heuvel and Dyson 2008). E2F-regulated genes are
required in dividing cells for proper DNA replication and subsequent
mitosis (Müller and Helin 2000; Ren et al. 2002). The basic unit of
E2F is a heterodimer composed of an E2F and a DP subunit. Eight
E2F genes have been characterized in mammals (Stevaux and Dyson
2002; Trimarchi and Lees 2002; van den Heuvel and Dyson 2008):
three activating E2Fs (E2F1~3), two DP interacting repressive E2Fs
(E2F4~5), and three DP independent repressive E2Fs (E2F6~8). The
E2F family members display partial redundancy as well as antagoniz-
ing functions; thus, it is challenging to elucidate the functions of in-
dividual mammalian E2Fs. The RB-E2F pathway is streamlined in
Drosophila because it contains only two E2Fs, the activator dE2F1
and the repressor dE2F2 (Frolov and Dyson 2004). Therefore, genetic
and developmental analyses using Drosophila as a model organism
may provide important insights into the mechanisms regulating the
RB-E2F pathway during development.
We used a modiﬁable dE2F1 RNA interference system in Drosoph-
ila to identify novel regulators of E2F1 activity. By conducting a dom-
inant modiﬁer genetic screen, we have identiﬁed a set of genetic
interactions between dE2F1 and members of the Polycomb group
(PcG) genes. Several PcG complexes have been characterized, includ-
ing polycomb repressive complex 1 (PRC1), PRC2, Pho-repressive
complex (PhoRC), dRING-associated factors, and the Polycomb
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Volume 2 | December 2012 | 1651repressive deubiquitinase complex [PR-DUB (Levine et al. 2004;
Schuettengruber et al. 2007; Schwartz and Pirrotta 2007; Müller
and Verrijzer 2009; Margueron and Reinberg 2011)]. Of these
complexes, the PRC2 contains the sole histone methyl-transferase,
Enhancer of zeste (E(z)), speciﬁc for histone 3 lysine 27 (H3K27).
Methylation of H3K27 by PRC2 is shown to facilitate the recruit-
ment of the PRC1 complex through direct binding with the chro-
modomain of Polycomb (Pc) (Cao et al. 2002; Fischle et al.
2003; Min et al. 2003; Cao and Zhang 2004). However, in vivo
r e g u l a t i o n so ft h e s ec o m p l e x e si nd e v e l o p m e n ta r el e s sw e l l
understood.
There are several reports linking PcG complexes to the RB-E2F
pathway in vertebrates. First, the INK4b-ARF-INK4a tumor suppres-
sor locus is regulated by the PcG complexes (Gil and Peters 2006). The
INK4b-ARF-INK4a locus is vertebrate-speciﬁc and encodes the INK4
family of inhibitors that target CDK4/6-cyclin D (CycD), which phos-
phorylate and inactivate pRB family members in mammals (Sherr
2004; Gil and Peters 2006). Second, RB was reported to regulate the
G2/M-phase transition by forming an E2F-RB-CtBP-HPC2 complex,
thus repressing the expression of cyclin A and Cdc2 in cultured hu-
man cells (Dahiya et al. 2001). Third, E2F6, one of the repressive E2F
family members in mammals, forms complexes with RYBP, Bmi1,
EPC1, and other PcG subunits (Trimarchi et al. 2001; Ogawa et al.
2002; Attwooll et al. 2005) and regulates Hox gene expression and
axial skeleton development in mouse (Storre et al. 2002; Courel et al.
2008). Finally, the RB-E2F pathway has been shown to regulate the
expression of certain PcG subunits, such as EZH2 and EED (Bracken
et al. 2003). Although it is not known whether these mechanisms are
conserved in evolution, these studies suggest that the interactions
between the RB-E2F pathway and PcG-mediated silencing can occur
at multiple levels.
In Drosophila, PcG complexes have been reported to regulate the
expression of several cell-cycle regulators. Polycomb responsive ele-
ments have been identiﬁed in the promoter and coding region of
dCycA and dE2f1 (Martinez et al. 2006). Similarly, the PhoRC subunit
Pleiohomeotic (Pho) and the PRC1 component Ph are found at the
promoters of dCycB, dDp, dE2f1,a n dRbf1 in Drosophila embryos
(Oktaba et al. 2008). These studies suggest a direct role for multiple
PcG complexes in regulating key Rb-E2F pathway components and
that PcG complexes may affect cell proliferation by controlling the
expression of different cell-cycle regulators in development. The rela-
tionships between PcG complexes and cell proliferation in different
developmental contexts are important and far from clear, thus further
investigations using diverse model systems and approaches are
necessary.
We have identiﬁed a set of genetic interactions between PcG genes
and dE2F1. As summarized in this report, our results suggest that PcG
complexes may directly repress the transcription of dE2f1 and certain
dE2F1 target genes. Together with the previous reports linking PcG
complexes to cell-cycle regulators (Martinez et al. 2006; Oktaba et al.
2008), our genetic analyses provide in vivo evidence that supports
a role for different PcG complexes in coordinating cell proliferation
and differentiation during Drosophila development by controlling the
expression of several key cell-cycle regulators.
MATERIALS AND METHODS
Generation of UAS-dE2f1-dsRNA (tissue-speciﬁc
dE2f1-RNAi) transgenic lines
A 650-bp fragment of DNA sequence was ampliﬁed by polymerase
chain reaction (PCR) using dE2f1 cDNA as the template, and the
primer sequences were 59-TTATTTCAAACGCCCTACCG-39 and
59-GAATTGCATCTGCAGTGAGC-39. This fragment was previously
used as the target sequence to generate double-strand RNA (dsRNA)
in our microarray analyses for dE2F1 target genes (Dimova et al.
2003). The PCR product was gel puriﬁed and subsequently subcl-
oned into the pWIZ vector in an inverted conﬁguration [for the
detailed procedure, see (Lee and Carthew 2003)] and veriﬁed by
sequencing. The ﬁnal pWIZ-dE2f1-dsRNA vector, as referred to as
“UAS-dE2f1-dsRNA” in the text, was injected into early Drosophila
embryos (w1118) to generate transgenic ﬂies. Approximately 30
different transgenic lines carrying one or multiple transgenes, as
indicated by their eye color because pWIZ carries mini-white as
a selection marker, were balanced, crossed, and recombined with
different Gal4 lines using standard genetic crosses. Because the
dE2f1dsRNA phenotypes in both the eye (w1118; GMR-Gal4,
UAS-dE2f1RNAi #10 or #8/+; +/+ at 25)a n dt h ew i n g( w1118;
ptc-Gal4, UASdE2f1dsRNA#3/+; +/+ at 2223)a r em o d i ﬁable
by known RB-E2F pathway factors in expected manners and the
phenotypes are fully penetrate, these two recombined stocks were
used for genetic analyses in this work.
Genetic screen using the Exelixis deﬁciency (Df) lines
Flies were maintained on standard cornmeal-yeast agar medium.
Exelixis Df lines and most of the mutant alleles used in this work
were obtained from the Bloomington Drosophila Stock Center. The
null allele of Polycomb (Pc3) allele was obtained from Dr. Antonio
Garcia-Bellido (Castelli-Gair et al. 1990). For genetic screen using
the Exelixis Df lines: approximately 5~10 female virgins from either
w1118; GMR-Gal4, UAS-dE2f1RNAi #10 (or #8)/CyO; +/+,o rw1118;
ptc-Gal4, UASdE2f1dsRNA#3/CyO; +/+ lines were crossed with 5~10
males from each Df line on second or third chromosomes, and the
crosses were maintained at either 25 (for the eye phenotype) or
22~23 (for the wing phenotype). As an example for the eye phe-
notype, the female F1 with the following genotypes were scored for
potential modiﬁcations: w1118; GMR-Gal4, UAS-dE2f1RNAi #10/Df
(2R/2L)Exel#; +,o rw1118; GMR-Gal4, UAS-dE2f1RNAi #10/+; Df
(3R/3L)Exel#/+. The reverse crosses were performed for Df lines
on the X chromosome and F1 female ﬂies with the following geno-
type were scored: Df(1)Exel#/w1118; GMR-Gal4, UAS-dE2f1RNAi
#10/+; +/+.
Scanning electron microscopy and measurement
of the L3-L4 intervein region
The F1 female ﬂies were stepwise dehydrated using ethanol, and
scanning electron micrographs were taken following standard proce-
dures at the Northeastern University. To measure L3-L4 intervein
region, wings are removed, brieﬂy treated with isopropanol and then
mounted in Canada Balsam (Sigma-Aldrich, St. Louis, MO). The
width of L3-L4 was measured under a Nikon i90 microscope using the
Nikon NIS Elements software.
Drosophila RNAi in SL2 cells and the MTT assay
The dsRNAs used in this work were synthesized using the RiboMax
Large Scale RNA Production Systems (Promega, Madison, WI)
following the manufacturer’s instructions. The following primer
sets were used to generate dsRNAs to dE2f1 (F: 59-CGAGTAAG
AAGCAGCAGCAC; R: 59-CTGCCGGTTCTATCGTGATT), Su(z)2
(F: 59-TCTGCTACCGGATTCTGCTTTACG; R: 59-AACTCCCTTTC
GATTCGCTGTCTT), Psc (F: 59-CAACGCCAAGCCGAACATC
AAATC; R: 59-AGCGGCTGGGGCGACTCATAAAC), Pc (F:
1652 | J.-Y. Ji et al.59-TGCCAATGCAATAGATTGTAAA; R: 59-CGCTTTGAATTG
CTGTTTTG), E(Pc) (F: 59-TCAGCCCTTCTACGATGCCTACTA;
R: 59-CTCGCGTCGCCTCACCATCTCCAG), and white with
T7 sequence (F: 59-CTAATACGACTCACTATAGGGAGGGAAGA
T G G C T C C G ;R :5 9-CTAATACGACTCACTATAGGGAGTTTCGCT
CAGCAAATG). Treatment of the Drosophila SL2 cells with 50 mg
of dsRNA was performed as described previously (Dimova et al.
2003). The white-dsRNA was used as a control, and it is also used
to normalize the total amount of dsRNA in codepletion experi-
ments. The MTT assay was performed as described (Hansen et al.
1989) in 96-well format, and the O.D. at 570nm was measured
using a standard plate-reader.
RNA preparation and quantitative reverse-transcription
(qRT)-PCR analysis
The total RNA isolation, quantiﬁcation, reverse transcription, and the
subsequent qRT-PCR analyses were performed as described pre-
viously (Zhao et al. 2012). The following primers were used for
qRT-PCR for data presented in Figure 4: stg (F: 59-AAACC
AGCTGCTCGGCATATT; R: 59-ATCTCAATTCACCGAACG
AGGA), rnrL (F-59-CGGTTAAGGCTCAATCCCTGT; R: 59-
TGGTTGCTCTTCCTGTTGCA), his2AvD (F: 59-TCACTC
CTCGCCACTTACAGCT; R: 59-CGACTTGTGTATGTGCG
GAATG), Mars (F: 59-ATCTTGGATCCTCAGCAGACGA;
R: 59-GGCATTCCATTGGATTCGC), Mcm 5 (F: 59-GAAGC
TAAAGAGCCGCTACGTG; R: 59-TCCAACTGACGCACA
GTGATG), PCNA (F: 59-GAATCGGCTAACCAGGAGAAGG;
R: 59-ACCACGCACGAGAAGTCTGTCT), Nebbish (F: 59-AGTCG
CATTGCCCTTAATCTGA; R: 59-ATGTCTGTCGCGGTGTA
TTGC), dE2f1 (F: 59-CTCTTTCTCCGCGTGTGGATT; R: 59-
GCGACGAAAAGCGAACTGAA), dCycA (F: 59-AACCACGA
ACCGCTGAACAA; R: 59-GGCAGCGTTGGAATTAGTTT), dCycE
(F: 59-ATGTGGCGCATAAGGTGCA; R: 59-CCCGATCTTT
GGCGGATAA), and rp49 gene (F: 59-ACAGGCCCAAGATCGT
GAAGA; R: 59-CGCACTCTGTTGTCGATACCCT) was used as
the internal loading control.
RESULTS
Tissue-speciﬁc knockdown of dE2F1 activity produces
modiﬁable phenotypes
Homozygous dE2f1 mutant animals die during larval development
(Duronio et al. 1995); thus, we used a dE2f1-dsRNA expression system
based on the pWIZ vector (Lee and Carthew 2003). This system
allows the tissue-speciﬁc expression of the target dsRNA (Hannon
2002) using the Gal4-UAS system (Brand et al. 1994; Lee and Carthew
2003). We generated multiple transgenic lines that produce a 650-bp
dsRNA from the dE2f1 gene under control of the UAS, designated as
“UAS-dE2f1-dsRNA” (see Materials and Methods for details). The
UAS-dE2f1-dsRNA transgenes were then crossed to multiple tissue-
speciﬁc Gal4 drivers and the resulting phenotypes were characterized.
By driving the expression of UAS-dE2f1-dsRNA using the eye-speciﬁc
GMR-Gal4 and the wing-speciﬁc patched-Gal4 (ptc-Gal4), we ob-
served phenotypes with 100% penetrance and limited variation. Ex-
pression of dE2f1-dsRNA under the control of GMR-Gal4 caused
a rough eye phenotype characterized by fused ommatidia (Figure
1B, compared with the control in Figure 1A), which we refer to as
the “dE2f1-dsRNA eye phenotype” hereafter. Expression of dE2f1-
dsRNA under the control of ptc-Gal4 reduces the L3-L4 intervein
region in the adult wing (Figure 3B, compared with the control in
Figure 3A), which is referred as the “dE2f1-dsRNA wing phenotype.”
To verify the speciﬁcity of the dE2f1-dsRNA2induced phenotypes,
we recombined different UAS-dE2f1-dsRNA lines to the GMR-Gal4 or
ptc-Gal4 drivers on the second chromosome (see Materials and Meth-
ods). Using these stocks, we then tested the capacity of components of
the Rb-E2F pathway to modifying the phenotypes. We observed that
the GMR-driven rough eye phenotypes generated by a weak allele of
dE2f1-dsRNA (line #10; Figure 1B) were enhanced by mutant alleles of
dE2f1 (Figure 1C). In contrast, the rough-eye phenotypes can be sup-
pressed by introducing a single copy of a UAS-dE2f1+ transgene (Fig-
ure 1D). We observed that even the strong effects of dE2f1-dsRNA
(line #8; Figure 1E) were suppressed by the overexpression of wild-
type dCycA (Figure 1F), dCycE (Figure 1G), or dCdk4-dCycD (Figure
Figure 1 Tissue-speciﬁc expression of dE2f1-
dsRNA generates phenotypes that can be modi-
ﬁed by known factors of the dE2F1 pathway. (A) A
normal Drosophila eye (w1118; GMR-Gal4/+; +/+).
(B) Expressing one copy of the UAS-dE2f1-dsRNA
(Line #10) generates a slight rough eye phenotype
(w1118; GMR-Gal4, UAS-dE2f1dsRNA#10/+; +/+),
which can be enhanced by reducing the endoge-
nous dE2f1 levels, as shown in (C) (w1118; GMR-
Gal4, UAS-dE2f1dsRNA#10/+; dE2f1i2/+), and
completely rescued by overexpressing wild-type
dE2f1,a ss h o w ni n( D )( w1118; GMR-Gal4, UAS-
dE2f1dsRNA#10/+; UAS-dE2f1+/+). A stronger
rough eye phenotype is generate when multi-
ple copies of UAS-dE2f1dsRNA (line #8) is ex-
pressed, as shown in (E) (w1118; GMR-Gal4,
UAS-dE2f1dsRNA#8/+; +/+). This stronger pheno-
type can be suppressed by overexpressing wild-type
dCycA (F: w1118; GMR-Gal4, UAS-dE2f1dsRNA#8/+;
UAS-dCycA+/+), wild-type dCycE (G: w1118; GMR-
Gal4, UAS-dE2f1dsRNA#8/UAS-dCycE+; +/+), or
dCdk4 and dCycD (H: w1118; GMR-Gal4, UAS-
dE2f1dsRNA#8/+; UAS-dCdk4+, UAS-dCycD+/+).
The scale bar (in H) is 200mm.
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the dE2f1-dsRNA phenotypes (data not shown). These genetic analy-
ses show that the dE2f1-dsRNA phenotypes are modiﬁed by compo-
nents of the Rb-E2F pathway in a predictable manner, suggesting that
the phenotypes are caused by speciﬁc reduction of dE2F1 activity. In
support of this, we observed reduced dE2F1 protein levels in both
immunostaining and Western blotting experiments when using tis-
sue-speciﬁce x p r e s s i o no fdE2f1-dsRNA (Morris et al. 2008). We also
ﬁnd that knockdown of dE2F1 in the wing imaginal discs results in
reduced expression of a PCNA-GFP reporter, which directly reﬂects
endogenous dE2F1 activity (Thacker et al. 2003; Morris et al. 2008).
Taken together, these molecular and genetic analyses suggest that the
dE2f1-dsRNA phenotypes result from the speciﬁc reduction of dE2F1
activity.
A dominant modiﬁer genetic screen to identify novel
regulators of dE2F1 activity
To identify novel regulators of dE2F1 in vivo, we performed a domi-
nant modiﬁer genetic screen based on the dE2f1-dsRNA phenotypes
described previously. The initial screen used the Exelixis Df collection
(459 lines), which was generated in an isogenic background and all of
the breakpoints are molecularly deﬁned (Parks et al. 2004). We con-
ducted a primary screen using the dE2f1-dsRNA eye phenotype be-
cause of ease of screening, and only Df lines that were able to modify
this eye phenotype were subsequently retested using the dE2f1-dsRNA
wing phenotype (Figure 2A). Thus, the Df lines that did not modify
the dE2f1-dsRNA eye phenotype (referred to as “no effect” or “NE” in
the tables) are excluded from further analysis (referred to as “not
determined” or “ND” in the tables). Although this screen strategy
may miss the modiﬁers that only affect the dE2f1-dsRNA wing phe-
notype, it enabled the identiﬁcation of general regulators of E2F1
activity rather than tissue-speciﬁcm o d i ﬁers.
From these screens, we identiﬁed 18 suppressor Df lines (Table 1)
and 23 enhancer Df lines (Table 2) that modiﬁed both dE2f1-dsRNA
phenotypes in the same fashion. The results of all Exelixis Df lines are
summarized in Supporting Information, Table S1. Because the dE2f1-
dsRNA phenotypes are based on RNAi, we tested the modiﬁer Df lines
on the GMR . white-Inverted Repeat (GMR-wIR) line, to identify gene
products that change RNAi efﬁciency rather than the E2F1 directly
(Lee et al. 2004). None of the enhancers and suppressors of the dE2f1-
dsRNA phenotypes affected the GMR-wIR eye color (Table 1 and Table
2), suggesting that the modiﬁers identiﬁed in our screen are bona ﬁde
regulators of dE2F1.
Su(z)2 is a strong suppressor of the
dE2f1-dsRNA phenotypes
One of the strongest suppressors (Df(2R)Exel6062)o ft h edE2f1-
dsRNA phenotypes was reported to delete only one characterized
gene, Su(z)2 (Parks et al. 2004). Df(2R)Exel6062 suppressed both
the eye phenotype (Figure 2C compared to the control Figure 2B)
and the wing phenotype (Figure 3C compared to the control Figure
3B). The Df(2R)Exel6062 line deletes a region of 54kb between two
P-element (XP vector) insertion lines d09185 and d02103 (Parks et al.
2004; Thibault et al. 2004). This deletion starts at 190bp region up-
stream of the neighboring gene Posterior sex comb (Psc), and includes
CG33798 (an uncharacterized gene with unknown function) and the
Su(z)2 gene (Parks et al. 2004).
To validate the suppressor gene of the dE2f1-dsRNA phenotypes,
we tested the capacity of additional alleles of Su(z)2 from the Bloo-
mington stock center (Su(z)21, Su(z)21.a1, Su(z)21.b7, Su(z)21.b8, Su(z)
24d1,S u (z)2k06344)t om o d i f yt h edE2F1-RNAi phenotypes (mutant
alleles of CG33798 are unavailable). These Su(z)2 mutant alleles
strongly suppressed the dE2f1-dsRNA (line #10) eye phenotype, and
to a less extent with the strong eye phenotype generated by dE2f1-
dsRNA (line #8; Figure 2E). Next, we validated these genetic interac-
tions identiﬁed in the eye by testing the effect of Su(z)2 mutants on the
dE2f1-dsRNA wing phenotype. Reducing Su(z)2 by either Df(2R)
Exel6062 (Figure 3C) or Su(z)21.a1 (Figure 3D) increased the L3-L4
intervein region of ptc-Gal4 UAS-dE2f1-dsRNA ﬂies compared with
controls (ptc-Gal4 UAS-dE2f1-dsRNA/+, Figure 3B). Measurement of
L3-L4 distance demonstrated signiﬁcant rescue of the intervein dis-
tance by these Su(z)2 alleles compared to the control (Figure 3E).
Figure 2 Su(z)2 is a strong suppressor of the dE2f1-dsRNA pheno-
types in the eye. (A) The design of the dominant modiﬁer genetic
screen using deﬁciency lines. (B-D) shows the modiﬁcation of the
dE2f1-dsRNA eye phenotype by Su(z)2 alleles. The eye phenotype
of GMR-Gal4, UAS-dE2f1dsRNA#8/+ (B) ﬂies can be strongly sup-
pressed by the Df(2R)Exel6062 line (C, the genotype is w1118;
GMR-Gal4, UAS-dE2f1dsRNA#8/Df(2R)Exel6062; +/+) and a null allele
of Su(z)2 (D, the genotype is w1118; GMR-Gal4, UAS-dE2f1dsRNA#8/
Su(z)21.b7; +/+). (E) Summary of the genetic interactions between Su(z)2
alleles and dE2f1-dsRNA phenotypes in the eye and wing. The suppres-
sive effect was ranked with scores from 1 to 5, with “1” being the
weakest and “5” the strongest. “0” means no genetic interaction. The
scale bar in (D) is 200mm.
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pressor of dE2f1-dsRNA phenotypes.
We then sought to extend this observation by examining
additional Su(z)2 alleles described recently (Emmons et al. 2009).
We examined the capacity of Su(z)2 point mutant alleles (Su(z)2s15,
Su(z)2s20, Su(z)2s21, Su(z)2s36, Su(z)2s84, Su(z)2s95,a n dSu(z)2sM)t o
suppress the dE2f1-dsRNA phenotypes. However, we did not observe
any obvious modiﬁcation of the E2F1-dsRNA phenotypes (data not
shown), indicating that these particular Su(z)2 point mutations are
insufﬁcient to modify these phenotypes. Similarly, we did not observe
any genetic interactions between dE2f1 and multiple alleles of the Su
(z)2 paralog, Psc (Pscs14, Psce22, Psch27, PscEY06547,a n dPsck07804; data
not shown), suggesting that Su(z)2 and Psc are not functionally re-
dundant in these genetic analyses.
n Table 1 Exelixis Df lines that dominantly suppress the dE2f1-dsRNA phenotypes
Bloomington
Stock No. Symbol Breakpoints
GMR-Gal4,
UAS-dE2f1-dsRNA#10a,b
ptc-Gal4,
UAS-dE2f1-dsRNA#3a,c GMR-wIR a
7699 Df(1)Exel6221 1B4;1B8 5 2 NE
7700 Df(1)Exel6223 1C4;1D2 5 4 NE
7723 Df(1)Exel6255 20A1;20B1 5 3 NE
7772 Df(2L)Exel7002 21B4;21B7 5 2 NE
7774 Df(2L)Exel8003 21D1;21D2 5 2 NE
7489 Df(2L)Exel6002 21D2;21D3 5 5 NE
8000 Df(2L)Exel6006 22B5;22D1 5 2 NE
7817 Df(2L)Exel8024 31A2;31B1 5 2 ND
7531 Df(2L)Exel6049 40A5;40D3 5 1 NE
7540 Df(2R)Exel6058 44C4;44D1 5 2 NE
7544 Df(2R)Exel6062 49E6;49F1 5 4 NE
7880 Df(2R)Exel9015 51F11;51F12 5 1 NE
7883 Df(2R)Exel7138 52D1;52D12 5 1 NE
7557 Df(2R)Exel6077 57F10;58A3 5 4 NE
7903 Df(2R)Exel7173 58D4;58E5 5 2 NE
7921 Df(3L)Exel9000 64A10;64B1 5 2 NE
7927 Df(3L)Exel7210 65A1;65A5 5 2 NE
7992 Df(3R)Exel9014 95B1;95D1 5 1 NE
a
The suppressive effect was ranked with scores from 1 to 5, with “1” the weakest and “5” the strongest. ND, not determined (this line is no longer available from the
Bloomington stock center); NE, no effect.
b
These crosses were maintained at 25.
c
These crosses were maintained at 22-23;s e eMaterials and Methods for the detailed genotypes analyzed.
n Table 2 Twenty-three enhancers from the Exelixis Df lines
Bloomington
Stock No. Symbol Breakpoints
GMR-Gal4,
UAS-dE2f1- dsRNA#10a,b
ptc-Gal4,
UAS-dE2f1- dsRNA#3a,c GMR-wIR a
7510 Df(2L)Exel6027 32D2;32D5 5 Lethal NE
7519 Df(2L)Exel6036 35B1;35B2 3 5 NE
7859 Df(2R)Exel7094 44A4;44B4 3 4 NE
7538 Df(2R)Exel6056 44A4;44C2 4 5 NE
7896 Df(2R)Exel7162 56F11;56F16 2 3 NE
7554 Df(2R)Exel6072 57B16;57D4 2 Lethal NE
7902 Df(2R)Exel7171 58C1;58D2 5 Lethal NE
7745 Df(3L)Exel6279 66A17;66B5 4 2 NE
7602 Df(3L)Exel6123 70D7;70E4 Pupal lethal Lethal NE
7611 Df(3L)Exel6132 74B2;74D2 3 1 NE
7614 Df(3L)Exel6135 76B11;76C4 5 Lethal NE
7624 Df(3R)Exel6145 83C1;83C4 5 Lethal NE
7627 Df(3R)Exel6148 84F12;85A2 Pupal lethal Lethal NE
7632 Df(3R)Exel6153 85D21;85E1 3 3 NE
7633 Df(3R)Exel6154 85E9;85F1 4 2 NE
7732 Df(3R)Exel6265 85F10;85F16 4 2 NE
7636 Df(3R)Exel6157 86B1;86B3 5 2 NE
7641 Df(3R)Exel6162 87A1;87B5 Pupal lethal Lethal NE
7649 Df(3R)Exel6170 87F10;87F14 1 5 NE
7742 Df(3R)Exel6275 88D1;88D7 5 Pupal lethal NE
7659 Df(3R)Exel6180 91B5;91C5 3 3 NE
7678 Df(3R)Exel6199 95F8;96A2 3 5 NE
7993 Df(3R)Exel8178 95F8;96A6 3 4 NE
a
The effect of enhancement was ranked with scores from 1 to 5, with “1” the weakest and “5” the strongest. NE, no effect.
b
These crosses were maintained at 25.
c
These crosses were maintained at 22-23; See Materials and Methods for the detailed genotypes analyzed.
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the dE2f1-dsRNA phenotypes
Having identiﬁed Su(z)2 as a suppressor of the dE2f1-dsRNA pheno-
types, we tested whether mutants other than Polycomb family mem-
bers, as well as genes that genetically interact with PcG, such as E(Pc)
(Jürgens 1985; Campbell et al. 1995), Mi-2 (Kehle et al. 1998), and
His2AvD (Swaminathan et al. 2005), could modify the dE2f1-dsRNA
phenotypes. We observed that mutations of Pc, pho, Su(z)12, Scm,a n d
His2AvD suppressed the dE2f1-dsRNA phenotypes, whereas E(Pc) and
Mi-2 behaved as enhancers (Table 3, Figure 3E). Importantly, com-
ponents of three PcG complexes, including PRC 1 complex (Pc, Scm),
PRC2 (Esc, Su(z)12), and PhoRC (Pho), were able to suppress the
dE2f1-dsRNA phenotypes (Table 3), suggesting that PcG may repress
dE2F1 activities. In addition, we observed that mutant alleles of several
PcG/TrxG genes, such as ash21, crm7, Dsp1EP355, eff8, lid10424, lidk06801,
PclEY08457, Sce1, trx1, trxEY13717, showed variable genetic interactions
ranging from suppression to no effect and enhancement of varied
degrees (data not shown). These variable interactions might reﬂect
the dynamic and complex interactions in vivo.
Next, we tested whether PcG mutants could modify phenotypes
caused by overexpression of dE2f1 alone or together with dDp,a sw e
described previously (Staehling-Hampton et al. 1999; Morris et al.
2008). We found that PcG mutants weakly enhanced phenotypes
associated with dE2f1 overexpression (Table 3), which is consistent
with the PcG role in repressing dE2F1 activities. Furthermore, to
examine whether the PcG genes affect RNAi efﬁciency, we used the
GMR-wIR line and tested several PcG mutants, including E(Pc)w3, Psc1,
Psce23, Psce25, Psch28, Su(z)21.b8, Su(z)2k06344, Su(z)24d1, Su(z)2s15, Su(z)
2s20, Su(z)2s95,a n dSu(z)2sM. We did not observe any of these lines
affected the light yellow eye color caused by knocking down of white
gene (data not shown), suggesting that Psc and Su(z)2 does not
affect RNAi process. Taken together, these genetic analyses revealed
in vivo regulation of dE2F1 by the PcG complexes, suggesting that
several PcG complexes cooperate to restrict dE2F1-dependent cell
proliferation.
Su(z)2 represses the expression of dE2f1 and critical
proliferation target genes
To examine the role of Su(z)2 in regulating dE2F1 activity, we
depleted Su(z)2 in cultured Drosophila SL2 cells and analyzed the
expression of dE2f1 and a subset of critical proliferation target genes
by qRT-PCR. Depletion of Su(z)2 signiﬁcantly increased the transcrip-
tion of dE2f1 and dE2F1 target genes including PCNA and dCycE
(Figure 4A). In contrast, reduction of Su(z)2 had little effect on
Rbf1 transcription and weakly up-regulates the expression of dE2f2
gene (Figure 4A). These results suggest that Su(z)2 constrains cell
proliferation by regulating the expression of dE2f1, PCNA,a n d
dCycE.
To test whether depletion of Su(z)2 could rescue the effect of
reduced dE2f1 transcription, we codepleted Su(z)2 and dE2f1 in
Drosophila SL2 cells and measured the effect on dE2F target gene
expression. As shown in Figure 4B, we observed that compared
to knocking down dE2f1 alone, codepletion of Su(z)2 and dE2F1
signiﬁcantly increased the expression of dE2f1 and several dE2F1
target genes, including PCNA, dCycE, string (stg,e n c o d i n gDro-
sophila CDC25 phosphatase), and Mcm5. These results suggest
that reduction of Su(z)2 is sufﬁcient to alleviate the effect of
dE2f1 depletion in SL2 cells, which is consistent with our obser-
vations that Su(z)2 mutants can suppress the dE2f1-dsRNA
phenotypes.
Next, to determine the biological consequence of codepleting
dE2f1 and Su(z)2, we conducted the dimethyltriazoldiphenyl tetrazo-
lium-formazan cell viability assays, also known as the MTT assay, to
analyze the kinetics of cell proliferation in SL2 cells. This assay is
based on mitochondrial reduction of a tetrazolium salt to a colored
formazan salt, which can be quantiﬁed by measuring the absorbance
at 570 nm, in living cells (Hansen et al. 1989). Depletion of dE2f1
impairs cellular proliferation, and cells arrest after 5 days of dsRNA
treatment (Figure 4C). Reducing Su(z)2 levels alone has little effect on
cell proliferation (Figure 4C); however, codepletion of dE2f1 and Su(z)
2 signiﬁcantly rescues the proliferation defects associated with dE2f1
Figure 3 Su(z)2 and additional PcG genes are strong
suppressors of the dE2f1-dsRNA phenotypes in the
wing. (A) Part of L3-L4 intervein region of a control Dro-
sophila wing (ptc-Gal4/+). Ptc-Gal4 is expressed in the
L3-L4 intervein region. At 22~23, when dE2f1-dsRNA
(line #3) is expressed under control of ptc-Gal4, the L3-
L4 intervein region is reduced by ~50%, as shown in (B)
(w1118; ptc-Gal4, UAS-dE2f1dsRNA#3/+; +/+). This wing
phenotype can be strongly suppressed by Df(2R)
Exel6062 (C: w1118; ptc-Gal4, UAS-dE2f1dsRNA#3/Df
(2R)Exel6062; +/+), or the Su(z)21.a1 allele (D: w1118;
ptc-Gal4, UAS-dE2f1dsRNA#3/Su(z)21.a1;+ / + ) .T h e
modiﬁcation of the wing phenotype can be quantiﬁed
by measuring the width of L3-L4 intervein region (E),
and the genotypes of data presented in (E) are as
follows: (a) w1118; ptc-Gal4/+; +; (b) w1118; ptc-Gal4,
UAS-dE2f1dsRNA#3/+; +; (c) w1118; ptc-Gal4, UAS-
dE2f1dsRNA#3/Df(2R)Exel6062;+ / + ;( d) w1118; ptc-Gal4,
UAS-dE2f1dsRNA#3/Su(z)21;+ / + ;( e) w1118; ptc-Gal4,
UAS-dE2f1dsRNA#3/Su(z)21.b7;+ / + ;( f) w1118; ptc-
Gal4, UAS-dE2f1dsRNA#3/Su(z)21.a1;+ / + ;a n d( g)
w1118; ptc-Gal4, UAS-dE2f1dsRNA#3/Su(z)2k06344; +/+;
(h) w1118; ptc-Gal4, UAS-dE2f1dsRNA#3/+; Pcf01890/+; (i) w1118; ptc-Gal4, UAS-dE2f1dsRNA#3/+; Pc3/+; (j) w1118; ptc-Gal4, UAS-dE2f1dsRNA#3/+;
His2AvD810/+; and (k) w1118; ptc-Gal4, UAS-dE2f1dsRNA#3/+; His2AvD05146/+. At least 15 to 25 wings of each genotype (a~k) were measured. Each
genotype (c~k) was compared with the control (b: w1118; ptc-Gal4, UAS-dE2f1dsRNA#3/+; +) and each comparison is highly signiﬁcant (P , 4.9E-06 based
on one-tailed t-test). For simplicity, “ptc-Gal4, UAS-dE2f1dsRNA#3” is referred as “PE3” in (E). The scale bar in (D) is 100mm.
1656 | J.-Y. Ji et al.depletion. In contrast, codepletion of dE2f1 and Psc (or E(Pc);d a t an o t
shown) had no effect in rescue of this defect (Figure 4D), which is
consistent with our genetic analyses (Table 3). Interestingly, depleting
Psc alone blocked cell proliferation (Figure 4D), consistent with the
recently reported role of Psc in regulating the G2-M progression by
directly affecting Cyclin B degradation (Mohd-Sarip et al. 2012). In
contrast to Psc, depleting Su(z)2 does not affect cell proliferation
(Figure 4C), suggesting that unlike Psc, Su(z)2 may not regulate the
turnover of CycB and nuclear division. Taken together, these results
suggest that Su(z)2 represses the transcription of dE2f1 and certain
dE2F1 target genes that are required for cell proliferation.
DISCUSSION
PcG and TrxG complexes play important roles in maintaining the
expression of many developmental genes in metazoans, and de-
regulation of their functions has been linked to human malignancy.
Here we identify genetic interactions between multiple compo-
nents of PcG complexes and a key cell-cycle regulator, E2F1, in
Drosophila.W eﬁnd that mutations compromising the PcG func-
tions suppress the defects caused by dE2F1-RNAi in the Drosophila
eye and wing. Our results suggest that PcG complexes may regulate
the key cell-cycle regulator dE2F1 and a subset of dE2F1 target
genes in Drosophila development. To our knowledge, this is the
ﬁrst work to show functionally that dE2F1 is affected by PcG
proteins, especially by Su(z)2.
Mutant alleles of Su(z)2, but not Psc, suppress
dE2f1-dsRNA phenotypes
Our dominant modiﬁer genetic screen using Exelixis Df mutants
identiﬁed Su(z)2 as a strong suppressor of the dE2F1-RNAi pheno-
types. By expanding our studies to mutations of other components of
the PcG complexes, we found a strong genetic link between PcG and
E2F1 activity. However, as summarized in Table 3, not all of mutant
alleles of the PcG genes tested modiﬁed the dE2f1-dsRNA phenotypes.
For example, although Su(z)2 and Psc are paralogs and their functions
are partially redundant (Brunk et al. 1991; van Lohuizen et al. 1991;
Soto et al. 1995; Wu and Howe 1995; Stankunas et al. 1998), we found
that only Su(z)2 could modify the E2F1-RNAi phenotypes. In addi-
tion, biochemical analyses suggest that both Psc and Su(z)2 share
similar activities in DNA binding, chromatin compacting, and chro-
matin remodeling inhibition (Lo et al. 2009). However, in multiple
analyses, including genetic tests based on phenotypes caused by over-
expression or knockdown of dE2F1, and experiments in cultured SL2
cells, we observed a consistent pattern of interaction with Su(z)2 but
not Psc (Figure 2, Figure 4, Table 3).
There are several potential explanations to these observations.
First, this screen was designed to identify the dominant modiﬁers and
perhaps mutations within some PcG genes remain above a critical
threshold during development. Second, the dE2f1-dsRNA phenotypes
in both the eye and wing are caused by reduction of dE2F1 protein
levels and dE2F1 activity (Morris et al. 2008). Because dE2F1 levels
n Table 3 Some of the PcG and TrxG genes dominantly modify the phenotypes caused by varied dE2F1 and RBF1
in the Drosophila eye and wing
Mutant Alleles
GMR-Gal4,
UAS-dE2f1-dsRNA#10a,b
ptc-Gal4,
UAS-dE2f1-dsRNA#3a,b
Act88F-Gal4,
UASdE2fa,b
GMR-Gal4,UASdE2f1,
UAS-dDpa,b
Suppressors
Asx1 Suppression (5) Suppression (1) Enhancement (1) NE
effmer4 Suppression (5) Suppression (2) NE NE
E(Pc)84DET66.1 Suppression (5) Suppression (1) NE NE
esc1 Suppression (4) NE ND ND
esc21 Suppression (5) Suppression (4) ND ND
His2AvD810 Suppression (5) Suppression (2) ND Enhancement (3)
His2AvD05146 Suppression (5) Suppression (3) ND Enhancement (3)
KisBG01657 Suppression (5) Suppression (2) NE NE
Pc3 Suppression (5) Suppression (5) ND Enhancement (4)
Pcf01890 Suppression (5) Suppression (2) ND Enhancement (1)
pho1 Suppression (5) Suppression (1) Enhancement (1) NE
ScmD1 Suppression (5) Suppression (4) ND ND
Su(z)21 Suppression (5) Suppression (4) ND Enhancement (1)
Su(z)21.a1 Suppression (5) Suppression (5) NE NE
Su(z)21.b7 Suppression (5) Suppression (3) Enhancement (1) NE
Su(z)2k06344 Suppression (5) Suppression (3) Enhancement (1) NE
Su(z)123 Suppression (5) Suppression (2) NE NE
tara1 Suppression (5) Suppression (1) ND NE
tou2 Suppression (5) Suppression (2) Enhancement NE
brm2 Suppression (5) Suppression (2) NE NE
trxKG08639 Suppression (5) Suppression (1) NE NE
Enhancers
E(Pc)w3 Enhancement (4) Enhancement (3) Suppression (1) ND
E(Pc)D4 Enhancement (5) Enhancement (5) Suppression (1) ND
Mi-2j3D4 Enhancement (4) Enhancement (1) Suppression (4) NE
Mi-2EY08138 Enhancement (5) Enhancement (1) ND ND
Su(z)31 Enhancement (5) Enhancement (4) Suppression (1) ND
taraBG01673 Pupal lethal Enhancement (4) Lethal Lethal
a
The effects of suppression or enhancement were ranked with scores from 1 to 5, with “1” the weakest and “5” the strongest; NE, no effect; ND, not determined.
b
These crosses were maintained at 25.
c
These crosses were maintained at 22-23;s e eMaterials and Methods for the detailed genotypes analyzed.
Volume 2 December 2012 | Interactions Between PcG and dE2F1 | 1657vary during the cell cycle (Shibutani et al. 2008), the dynamic inter-
actions between dE2F1 and PcG gene products may determine
whether a phenotypic interaction can be visualized in these adult
tissues. Perhaps Su(z)2 has a more important role in the tissues we
used to screen for E2F1 modiﬁers, and our genetic tests alone still
cannot rigorously rule out the potential redundant functions of Su(z)2
and Psc. Third, as Psc regulates mitotic progression independently of
the transcriptional functions of the canonical PcG complexes, it is
likely that Su(z)2 and Psc regulate different sets of targets (Mohd-
Sarip et al. 2012). Unlike Psc (Figure 4D), depleting Su(z)2 alone does
not affect cell proliferation (Figure 4C), suggesting that Su(z)2 may
not have a role in regulating CycB degradation. Nevertheless, the
mitotic effects of Psc may mask its role in regulating dE2f1 transcrip-
tion. Thus, our results are not sufﬁcient to exclude the possibility that
Psc might have a redundant role with Su(z)2 in repressing the expres-
sion of dE2f1. Additional molecular and biochemical analyses are
necessary to further dissect the difference between these two paralog
proteins.
The dE2f1 gene is a target repressed by PcG complexes
There are several lines of evidence suggesting that dE2F1 activity is
regulated by PcG and TrxG complexes. Mutant alleles of subunits of
the SWI/SNF chromatin-remodeling complex (Grimaud et al. 2006),
such as brahma (brm)a n dmoira (mor), have been shown to domi-
nantly modify the rough eye phenotype caused by overexpression of
dE2f1 and its heterodimeric partner dDp (Staehling-Hampton et al.
1999). Subunits of the Domino chromatin-remodeling complex (PcG-
like L3mbt and the related dSfmbt) negatively regulate transcription of
an artiﬁcial dE2f1 reporter gene (Lu et al. 2007). ChIP assays have
identiﬁed both Ph and Pho on the promoter and coding regions of the
dE2f1 gene in Drosophila embryos (Oktaba et al. 2008).
PcG complexes regulate methylation of H3K27 in Drosophila (Cao
and Zhang 2004), we therefore analyzed the status of H3K27 meth-
ylation during development or in several Drosophila cell lines using
chromatin immunoprecipitation (ChIP) followed by microarray hy-
bridization (ChIP-chip) or high-throughput sequencing (ChIP-Seq)
data sets deposited to modENCODE (Celniker et al. 2009) (http://
modencode.oicr.on.ca/fgb2/gbrowse/ﬂy/). We found that the genomic
loci of dE2f1, dCycE and stg display mono-, di-, or trimethylation of
H3K27 (H3K27me1/2/3) during development or in Drosophila cell
lines, including SL2, Kc, and BG3 cells (see Figure S1, Figure S2,
Figure S3,a n dFigure S4 for details), suggesting that PcG may
directly regulate the expression of these genes. dCycE and stg are
critical dE2F1 target genes, which regulate the G1/S-phase and the
G2/M-phase transition of the cell cycle, respectively (Edgar and
Lehner 1996; Dyson 1998). We did not observe obvious H3K27me
modiﬁcation of other dE2F1 target genes such as PCNA and Mcm5
(data not shown), suggesting that the effect of Su(z)2 on expression of
these genes (Figure 4B) is likely indirect through dE2f1.T o g e t h e r ,
these observations suggest that PcG complexes may repress the
expression of dE2f1 and a subset of dE2F1 target genes during
development.
These observations are consistent with our genetic studies and
suggest the suppressive effect of PcG mutants on dE2f1-dsRNA phe-
notypes is caused by derepression of dE2f1 and certain dE2F1 target
genes, which compensates for the effect of dE2f1-depletion. Together
with previous published observations linking PcG complexes to cell-
cycle regulators, such as dCycA (Martinez et al. 2006), dCycB (Oktaba
et al. 2008), dCycE (Brumby et al. 2002), and dE2f1 (Oktaba et al.
2008), our observations provide further support for the role of PcG in
repressing the transcription of cell-cycle genes, including dE2f1,
dCycE,a n dstg (Figure 4 and Figure S4).
Regulation of the key cell-cycle regulators by PcG complexes may
present a general mechanism to coordinate cellular differentiation and
proliferation during development. Disrupting the coordination be-
tween differentiation and proliferation may result in abnormal
development and may contribute to tumorigenesis. Consistent with
this notion, accumulating evidence shows that the PcG complexes are
misregulated in a wide variety of human cancers (Sparmann and van
Lohuizen 2006; Ballestar and Esteller 2008; Bracken and Helin 2009).
This study, together with previous reports in Drosophila (Staehling-
Hampton et al. 1999; Brumby et al. 2002; Grimaud et al. 2006; Martinez
et al. 2006; Lu et al. 2007; Oktaba et al. 2008), suggest that mutations
compromising PcG activity would elevate E2F activity, thereby pro-
viding cells with a strong tumorigenic advantage. Further studies are
necessary to elucidate how these two important regulatory mechanisms
are coordinated during cellular differentiation and proliferation in
development.
Figure 4 Su(z)2 regulates the transcription of dE2f1
and some of the dE2F1 target genes. (A) Knocking
down Su(z)2 (gray bars) leads to up-regulation of
dE2f1, and some of the dE2F1 target genes, such
as PCNA, dCycE, and to a less extent dE2f2 and no
effect of Rbf1, based on qRT-PCR assay. The sam-
ples treated with dE2f1-dsRNAs (white bars) serve as
a positive control, and T7-dsRNA treated samples
are negative controls. (B) Codepletion (gray bars)
of Su(z)2 and dE2f1 suppresses the effect of dE2f1-
dsRNA treatment and leads to increased expression
of dE2f1, PCNA, dCycE, stg, and mcm5. The total
dsRNAs are normalized with T7-dsRNA. (C and D)
Effect of dsRNA treatment of the growth of SL2 cells:
knocking down of Su(z)2 (C), but not Psc (D), sup-
presses the effect of dE2f1-dsRNA treatment at day
5. For each sample, the total amount of dsRNA is
normalized with white-dsRNA and cell viability was
determined by using the dimethyltriazoldiphenyl tet-
razolium-formazan assay after 1, 3 or 5 days of
dsRNA treatment.
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